Skip to main content
logo
VSE Corporation (VSEC)
NASDAQ: VSEC · Real-Time Price · USD
154.08
+0.58 (0.38%)
At close: Aug 11, 2025, 4:00 PM
153.64
-0.44 (-0.29%)
After-hours: Aug 11, 2025, 4:10 PM EDT

Oncternal Therapeutics Revenue

VSE Corporation had revenue of $272.14M in the quarter ending June 30, 2025, with 41.13% growth. This brings the company's revenue in the last twelve months to $1.25B, up 52.47% year-over-year. In the year 2024, VSE Corporation had annual revenue of $1.08B with 25.53% growth.

Revenue (ttm)
$1.25B
Revenue Growth
+52.47%
P/S Ratio
2.45
Revenue / Employee
$895,075
Employees
1,400
Market Cap
3.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.08B219.64M25.53%
Dec 31, 2023860.49M191.04M28.54%
Dec 31, 2022669.45M188.06M39.07%
Dec 31, 2021481.38M-180.28M-27.25%
Dec 31, 2020661.66M-90.97M-12.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
RTX Corporation83.60B
The Boeing Company75.33B
Lockheed Martin71.84B
Caterpillar63.14B
Deere & Company45.38B
General Electric Company41.61B
Honeywell International39.99B
GE Vernova36.62B
Revenue Rankings

VSEC News

More News